Correlation Between Reneo Pharmaceuticals and Freeline Therapeutics
Can any of the company-specific risk be diversified away by investing in both Reneo Pharmaceuticals and Freeline Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reneo Pharmaceuticals and Freeline Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reneo Pharmaceuticals and Freeline Therapeutics Holdings, you can compare the effects of market volatilities on Reneo Pharmaceuticals and Freeline Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reneo Pharmaceuticals with a short position of Freeline Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reneo Pharmaceuticals and Freeline Therapeutics.
Diversification Opportunities for Reneo Pharmaceuticals and Freeline Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Reneo and Freeline is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and Freeline Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Freeline Therapeutics and Reneo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reneo Pharmaceuticals are associated (or correlated) with Freeline Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Freeline Therapeutics has no effect on the direction of Reneo Pharmaceuticals i.e., Reneo Pharmaceuticals and Freeline Therapeutics go up and down completely randomly.
Pair Corralation between Reneo Pharmaceuticals and Freeline Therapeutics
Given the investment horizon of 90 days Reneo Pharmaceuticals is expected to under-perform the Freeline Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Reneo Pharmaceuticals is 2.23 times less risky than Freeline Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Freeline Therapeutics Holdings is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 224.00 in Freeline Therapeutics Holdings on August 31, 2024 and sell it today you would earn a total of 207.00 from holding Freeline Therapeutics Holdings or generate 92.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 9.55% |
| Values | Daily Returns |
Reneo Pharmaceuticals vs. Freeline Therapeutics Holdings
Performance |
| Timeline |
| Reneo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
| Freeline Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reneo Pharmaceuticals and Freeline Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reneo Pharmaceuticals and Freeline Therapeutics
The main advantage of trading using opposite Reneo Pharmaceuticals and Freeline Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reneo Pharmaceuticals position performs unexpectedly, Freeline Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freeline Therapeutics will offset losses from the drop in Freeline Therapeutics' long position.| Reneo Pharmaceuticals vs. Prime Medicine, Common | Reneo Pharmaceuticals vs. Ginkgo Bioworks Holdings | Reneo Pharmaceuticals vs. Ocean Biomedical | Reneo Pharmaceuticals vs. Royalty Pharma Plc |
| Freeline Therapeutics vs. Cns Pharmaceuticals | Freeline Therapeutics vs. ZyVersa Therapeutics | Freeline Therapeutics vs. Immix Biopharma | Freeline Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |